HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 24, 2009--
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that
Larry Hsu, Ph.D., President and Chief Executive Officer of Impax
Laboratories, Inc., will preside over the NASDAQ Opening Bell on Monday,
August 24, 2009 at the NASDAQ MarketSite® in New York City’s Times
Square.
Larry Hsu, Ph.D., said: “Our relisting on the NASDAQ Global Market in
March 2009 was an exciting time for Impax in re-establishing itself as a
public company. I am honored to ring the NASDAQ Opening Bell as it
represents a tremendous amount of achievement due to the dedication and
hard work of our employees. This dedication has led to strong growth at
the Company and will continue to be the driving force behind the
successful execution of our dual-focus strategy and long-term value
creation.”
The event will be broadcast live on national business television at 9:30
a.m. EST, as well as webcast live on NASDAQ’s Web site http://www.nasdaq.com/about/marketsitetowervideo.asx
and on the NASDAQ MarketSite® Tower in New York City’s Times Square.
About Impax Laboratories, Inc.:
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.
About NASDAQ OMX:
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It
delivers trading, exchange technology and public company services across
six continents, with over 3,700 listed companies. NASDAQ OMX Group
offers multiple capital raising solutions to companies around the globe,
including its U.S. listings market; NASDAQ OMX Nordic, NASDAQ OMX
Baltic, NASDAQ OMX First North; and the U.S. 144A sector. The company
offers trading across multiple asset classes including equities,
derivatives, debt, commodities, structured products and ETFs.
NASDAQ OMX Group technology supports the operations of over 70
exchanges, clearing organizations and central securities depositories in
more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not
legal entities but describe the common offering from NASDAQ OMX Group
exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga,
and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com.
Source: Impax Laboratories, Inc.
Impax Laboratories, Inc.
Mark Donohue, 215-933-3526
Sr.
Director Investor Relations
www.impaxlabs.com